Els Verhoeven
Impact in
-
- Cancer Mechanisms and Therapy
- Oncology top 5%
- Cancer-related Molecular Pathways
- Peptidase Inhibition and Analysis
Papers in
- Genetics 7
- Genetics and Neurodevelopmental Disorders 5
-
- Cancer Mechanisms and Therapy 3
- Co-authors
- Ed SchuuringMaarten van LohuizenRob MichalidesJohn AllenW. J. MooiAnton BernsJos DomenAnders H. Lund
- Journals
- Oncogene (3 papers)Molecular and Cellular Biology (3 papers)The EMBO Journal (2 papers)Proceedings of the National Academy of Sciences (2 papers)Methods in enzymology on CD-ROM/Methods in enzymology (1 paper)
- Partner nations
- NetherlandsUnited StatesAustria
In The Last Decade
Els Verhoeven
21 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 80
- Pathology and Forensic Medicine 544
- Oncology 762
- Molecular Biology 1.7k
- Immunology and Allergy 116
- Cancer Research 272
Countries citing papers authored by Els Verhoeven
This map shows the geographic impact of Els Verhoeven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Els Verhoeven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Els Verhoeven more than expected).
Fields of papers citing papers by Els Verhoeven
This network shows the impact of papers produced by Els Verhoeven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Els Verhoeven. The network helps show where Els Verhoeven may publish in the future.
Co-authors
The 25 scholars most cited alongside Els Verhoeven, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2021 | 18 | |
| 4 | 2013 | 69 | |
| 5 | 2011 | 1 | |
| 6 | 2008 | 32 | |
| 7 | 2005 | 256 | |
| 8 | 2004 | 266 | |
| 9 | 2004 | 11 | |
| 10 | 2003 | 284 | |
| 11 | 2002 | 188 | |
| 12 | 1998 | 34 | |
| 13 | 1997 | 135 | |
| 14 | 1997 | 215 | |
| 15 | 1995 | 156 | |
| 16 | 1993 | 38 | |
| 17 | 1993 | 142 | |
| 18 | Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. | 1992 | 175 |
| 19 | Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. | 1992 | 285 |
| 20 | 1987 | 33 |
About Els Verhoeven
Els Verhoeven is a scholar working on Genetics, Pathology and Forensic Medicine, Cancer Research, Molecular Biology and Cell Biology, having authored 21 papers that have together received 2.4k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (6 papers), Genetics and Neurodevelopmental Disorders (5 papers), Cancer-related gene regulation (5 papers), Cancer Mechanisms and Therapy (3 papers), Peptidase Inhibition and Analysis (3 papers), Genomics and Chromatin Dynamics (3 papers), RNA modifications and cancer (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (544 citations), Oncology (762 citations), Molecular Biology (1.7k citations), Immunology and Allergy (116 citations) and Cancer Research (272 citations). Els Verhoeven has collaborated with scholars based in Netherlands, United States and Austria. Frequent co-authors include Ed Schuuring, Maarten van Lohuizen, Rob Michalides, John Allen, W. J. Mooi, Anton Berns, Jos Domen, Anders H. Lund, Jos Jonkers and Martijn C. Nawijn. Their work appears in journals such as Oncogene, Molecular and Cellular Biology, The EMBO Journal, Proceedings of the National Academy of Sciences and Methods in enzymology on CD-ROM/Methods in enzymology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.